Table 1.
Program characteristics of included articles (N = 25)
| Article study design/type | N (%) |
|---|---|
| Commentary or program description | 18 (72%) |
| Research with quantitative outcomes | 4 (16%) |
| Research with qualitative outcomes | 2 (8%) |
| Case report | 1 (4%) |
| Country | |
| United States | 13 (52%) |
| Puerto Rico | 1 (4%) |
| South Africa | 1 (4%) |
| United Kingdom | 1 (4%) |
| Ireland | 1 (4%) |
| India | 2 (8%) |
| Australia | 3 (12%) |
| Canada | 1 (4%) |
| Spain | 1 (4%) |
| Italy | 1 (4%) |
| Care setting | |
| Substance use treatment | 13 (52%) |
| Outreach/harm reduction | 7 (28%) |
| Correctional facility | 2 (8%) |
| Mobile clinic | 2 (8%) |
| Primary care/general practitioner | 1 (4%) |
| Type of organization | |
| Academic institution | 7 (28%) |
| Government/academic partnership | 3 (12%) |
| Government | 4 (16%) |
| Non-for-profit organization | 3 (12%) |
| Independent clinic | 7 (28%) |
| Commercial laboratory | 1 (4%) |
| Services described | |
| OUD Treatment | 21 (84%) |
| Harm reduction | 1 (4%) |
| OUD Treatment and Harm reduction | 3 (12%) |
| Types of medications offered | |
| Sublingual buprenorphine | 16 (64%) |
| Extended release buprenorphine | 3 (12%) |
| Methadone | 11 (44%) |
| Extended-release naltrexone | 1 (4%) |
| Naloxone | 12 (48%) |
| New vs. modification of program | |
| New | 4 (16%) |
| Modification | 21 (84%) |